NOXXON Pharma AG Revenue and Competitors
Estimated Revenue & Valuation
- NOXXON Pharma AG's estimated annual revenue is currently $8M per year.
- NOXXON Pharma AG's estimated revenue per employee is $201,000
Employee Data
- NOXXON Pharma AG has 40 Employees.
- NOXXON Pharma AG grew their employee count by 14% last year.
NOXXON Pharma AG's People
Name | Title | Email/Phone |
---|
NOXXON Pharma AG Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.7M | 88 | 7% | N/A | N/A |
#2 | $89.4M | 445 | 9% | N/A | N/A |
#3 | $32.4M | 161 | 25% | N/A | N/A |
#4 | $44.4M | 221 | 7% | N/A | N/A |
#5 | $120.2M | 427 | 17% | $446.2M | N/A |
#6 | $54.3M | 270 | 10% | N/A | N/A |
#7 | $49.6M | 247 | 52% | N/A | N/A |
#8 | $21.9M | 109 | -1% | N/A | N/A |
#9 | $16.5M | 82 | 4% | N/A | N/A |
#10 | $26.7M | 133 | 25% | N/A | N/A |
What Is NOXXON Pharma AG?
NOXXON Pharma is a clinical-stage biopharmaceutical company whose core focus is on improving cancer treatment by targeting the tumor microenvironment. NOXXON's goal is to significantly enhance the effectiveness of cancer treatments including immuno-oncology approaches (such as immune checkpoint inhibitors) and current standards of care (such as chemotherapy and radiotherapy). NOXXON's Spiegelmer® platform has generated a proprietary pipeline of clinical-stage assets including its lead cancer candidate NOX-A12, which is the subject of a clinical immuno-oncology collaboration agreement with Merck & Co. / MSD (NYSE: MRK) to study NOX-A12 combined with KEYTRUDA® (pembrolizumab) in pancreatic and colorectal cancer. NOXXON's pipeline also contains NOX-E36, which targets other tumor microenvironment targets implicated in cancer spread and immune privilege of tumors.
keywords:N/AN/A
Total Funding
40
Number of Employees
$8M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NOXXON Pharma AG News
Noxxon Pharma AG, MedImmune, LLC, Novartis AG, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Celgene Corporation,...
Novartis AG; Noxxon Pharma AG; Pfizer Inc; Taiho Pharmaceutical Co Ltd; Taiwan Liposome Company Ltd; Tarveda Therapeutics Inc. On the global...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.8M | 40 | -11% | N/A |
#2 | $4.5M | 40 | 0% | N/A |
#3 | $8.6M | 40 | 11% | N/A |
#4 | $4.6M | 40 | 14% | N/A |
#5 | $4.5M | 40 | -9% | N/A |